Clinical

Dataset Information

Safety Study of Regorafenib and SIR-Spheres Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases


ABSTRACT: The purpose of this study is to determine the safety of regorafenib, an antiangiogenic drug, when combined with radioembolization using SIR-Spheres microspheres in the treatment of colorectal cancer (CRC) that has spread to the liver.

DISEASE(S): Neoplasm Metastasis,Colorectal Neoplasms

PROVIDER: 2170931 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR